InvestSMART

ResMed Inc. (ASX: RMD) - Announcements

Current share price for RMD : $30.260 0.47 (1.58%)+

ASX company news and announcements for ResMed Inc. (RMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ResMed Inc. (RMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ResMed Inc. (RMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ResMed Inc. (RMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$43,702 RMD to Report First Quarter Fiscal 2024 Results 6 Oct 2023 8:21AM $23.280 $30.260 risen by 29.98%
$43,702 Notice of Annual General Meeting Additional Materials 6 Oct 2023 8:21AM $23.280 $30.260 risen by 29.98%
$43,702 Notice of Annual General Meeting/Proxy Form 6 Oct 2023 8:20AM $23.280 $30.260 risen by 29.98%
$43,702 Statement of CDIs on issue - RMD 4 Oct 2023 1:17PM $22.940 $30.260 risen by 31.91%
$43,702 Statement of CDIs on issue - RMD 6 Sep 2023 11:44AM $23.760 $30.260 risen by 27.36%
$43,702 Update - Dividend/Distribution - RMD 21 Aug 2023 5:27PM $26.080 $30.260 risen by 16.03%
$43,702 ResMed Form 10-k Annual Report 14 Aug 2023 9:41AM $27.470 $30.260 risen by 10.16%
$43,702 Dividend/Distribution - RMD 4 Aug 2023 8:20AM $33.850 $30.260 fallen by 10.61%
$43,702 ResMed Announces Results for the Fourth Quarter of FY2023 4 Aug 2023 8:20AM $33.850 $30.260 fallen by 10.61%
$43,702 Statement of CDIs on issue - RMD 3 Aug 2023 8:18AM $33.990 $30.260 fallen by 10.97%
$43,702 RMD to Report Fourth Quarter Fiscal 2023 Results 7 Jul 2023 8:20AM $32.320 $30.260 fallen by 6.37%
$43,702 Statement of CDIs on issue - RMD 6 Jul 2023 12:30PM $32.350 $30.260 fallen by 6.46%
$43,702 Statement of CDIs on issue - RMD 6 Jun 2023 8:52AM $33.250 $30.260 fallen by 8.99%
$43,702 FORM SD 29 May 2023 8:18AM $33.310 $30.260 fallen by 9.16%
$43,702 Update - Dividend/Distribution - RMD 15 May 2023 10:11AM $34.880 $30.260 fallen by 13.25%
$43,702 Statement of CDIs on issue - RMD 4 May 2023 9:59AM $35.330 $30.260 fallen by 14.35%
$43,702 FORM 10Q for Qtr ended March, 2023 1 May 2023 9:40AM $33.710 $30.260 fallen by 10.23%
$43,702 Dividend/Distribution - RMD 28 Apr 2023 8:15AM $33.730 $30.260 fallen by 10.29%
$43,702 ResMed Announces Results for the Third Quarter of FY2023 28 Apr 2023 8:15AM $33.730 $30.260 fallen by 10.29%
$43,702 RMD to Report Third Quarter Fiscal 2023 Results 11 Apr 2023 8:15AM $33.130 $30.260 fallen by 8.66%
$43,702 Statement of CDIs on issue - RMD 4 Apr 2023 12:50PM $32.450 $30.260 fallen by 6.75%
$43,702 Company Secretary Appointment/Resignation 31 Mar 2023 8:20AM $32.180 $30.260 fallen by 5.97%
$43,702 Statement of CDIs on issue - RMD 3 Mar 2023 11:33AM $31.820 $30.260 fallen by 4.90%
$43,702 Update - Dividend/Distribution - RMD 10 Feb 2023 1:00PM $31.050 $30.260 fallen by 2.54%
$43,702 Statement of CDIs on issue - RMD 3 Feb 2023 9:35AM $32.000 $30.260 fallen by 5.44%

301 - 325 of 703 results

Page 13 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.